EDITORS EMULSION 17th July 2018

Warm Greetings!

To advance the benefits of medical technology, we must have the right public policies to support investment, innovation and patient access. Today, the government is at a crossroads, and the path it chooses will decide if Indian patients can demand and receive quality treatment at affordable prices, or if they must face an uncertain future marred by inferior care - with inadequate or inappropriate technology, and frequent shortages thus denying access and choice. Read about the various aspects of health care costs in the context of innovations to improve longevity and quality of life under PSM India Capsules.

The Central Drugs Standard Control Organisation (CDSCO) will constitute an expert sub-committee to weigh the pros and cons of a ‘trace and track’ mechanism proposed for the top 300 drug brands in the country, it is learnt. The fate of the initiative, aimed at weeding out counterfeits from the market, now depends on the report of this panel which includes representatives of drug manufacturers. Get an insight into this decision and other important government implementations like the Pharma Sahi Daam app to cross check drug prices, revision of retail prices of 56 formulations and curbs on syringe sale getting into action under drug laws and policy injections.

While the government works towards the betterment of the Indian patient it regularly safe guards the interests of the Pharma companies as well. Under Pharma injections, read about how the Union government is ready to roll out an interest subvention scheme for small pharma companies, who wish to upgrade their infrastructure and technology. Under the scheme, the government will bear interest burden of 6% on loans up to ₹4 crore for a period of three years.

We constantly endeavour not only to collate important information from the health and medicine world but also to create a connect with consumers all over. We welcome articles and write ups from our readers and are glad to feature them under the section titled Subscriber’s Symptoms. This issue features a contribution by Dr.Pratima on the breakthrough research on ‘Self Eating Cells’ by Nobel prize winner

Do not hesitate to mail your comments on this newsletter to help us improve further. We appreciate your support and trust in us and are happy to have you as our loyal reader.

Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pooja@patientsafetyaccess.org

Stay Healthy. Stay Safe.

Pooja Mishra Khaitan

Editor-in-Chief,

The Prescription